Europe Next-generation Antibody Market to 2028 By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Next-generation Antibody Market – By Therapeutic Area

1.3.2 Europe Next-generation Antibody Market – By Technology

1.3.3 Europe Next-generation Antibody Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Next-generation Antibody Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. Next-generation Antibody Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cancer

5.1.2 Growing Demand for Next-Generation Antibody Therapeutics

5.2 Market Restraints

5.2.1 Complications Associated with Manufacturing and Approvals

5.3 Future Trends

5.3.1 Developments in Next-Generation Antibodies

5.4 Impact Analysis

6. Next-generation Antibody Market–Europe Analysis

6.1 Europe Next-generation Antibody Market Revenue Forecast and Analysis

7. Europe Next-generation Antibody Market Revenue and Forecasts To 2028– by Therapeutic Area

7.1 Overview

7.2 Europe Next-generation Antibody Market, By Therapeutic Area, 2021 & 2028 (%)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Autoimmune or Inflammatory

7.4.1 Overview

7.4.2 Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Next-generation Antibody Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Europe Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

8.3 Antibody-drug conjugates

8.3.1 Overview

8.3.2 Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.4 Bispecific antibodies

8.4.1 Overview

8.4.2 Bispecific antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.5 Fc engineered antibodies

8.5.1 Overview

8.5.2 Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.6 Antibody fragments and antibody-like proteins

8.6.1 Overview

8.6.2 Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biosimilar antibody products

8.7.1 Overview

8.7.2 Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

9. Next-generation Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 Europe: Next-generation Antibody Market

9.1.1 Overview

9.1.2 Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3 Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.4 Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5 Europe: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

9.1.5.1 Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 Overview

9.1.5.1.2 Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3 Germany: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.4 Germany: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5.2 France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 Overview

9.1.5.2.2 France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 France: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.4 France: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5.3 UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 Overview

9.1.5.3.2 UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3 UK: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.4 UK: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5.4 Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.4.1 Overview

9.1.5.4.2 Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.4.3 Italy: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.4.4 Italy: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5.5 Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.5.1 Overview

9.1.5.5.2 Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.5.3 Spain: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.5.4 Spain: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.1.5.6 Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.6.1 Overview

9.1.5.6.2 Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.6.3 Rest of Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.1.5.6.4 Rest of Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10. Impact Of COVID-19 Pandemic on Next-generation Antibody Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Next-generation Antibody Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 F. HOFFMANN-LA ROCHE LTD.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Seagen Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Takeda Pharmaceutical Company Limited

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Amgen Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pfizer Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Catalent Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AstraZeneca

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. New Cancer Cases Registered Worldwide, 2020

Table 2. Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 6. France: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 7. France: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 8. UK: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 9. UK: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 10. Italy: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 12. Spain: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 13. Spain: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 16. Organic Developments in the Next-generation Antibody Market

Table 17. Inorganic Developments in the Next-generation Antibody Market

Table 18. Glossary of Terms

LIST OF FIGURES

Figure 1. Next-generation Antibody Market Segmentation

Figure 2. Next-generation Antibody Market, By Country

Figure 3. Europe Next-generation Antibody Market Overview

Figure 4. Oncology Segment Held Largest Share of Therapeutic Area Segment in Next-generation Antibody Market

Figure 5. Global Next-generation Antibody Market- Leading Country Markets (US$ Million)

Figure 6. Europe: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Next-Generation Antibody Market Impact Analysis of Driver and Restraints

Figure 9. Europe Next-generation Antibody Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 10. Europe Next-generation Antibody Market, by Therapeutic Area, 2021 & 2028 (%)

Figure 11. Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Europe Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

Figure 14. Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15. Bispecific antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16. Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18. Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Europe: Next-generation Antibody Market, by Key Country – Revenue (2021) (US$ Million)

Figure 20. Europe: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

Figure 22. Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Impact of COVID-19 Pandemic in European Country Markets